<ruby id="3p5pr"><table id="3p5pr"><ol id="3p5pr"></ol></table></ruby>
<dd id="3p5pr"></dd>
<button id="3p5pr"><tr id="3p5pr"></tr></button>
<em id="3p5pr"></em>
<button id="3p5pr"><acronym id="3p5pr"></acronym></button>

      <span id="3p5pr"></span>
      <dd id="3p5pr"><center id="3p5pr"></center></dd>
      <dd id="3p5pr"><noscript id="3p5pr"></noscript></dd>

        <tbody id="3p5pr"></tbody>
          <nav id="3p5pr"></nav>

            <th id="3p5pr"></th>
            <li id="3p5pr"></li>
            <th id="3p5pr"></th><rp id="3p5pr"></rp><em id="3p5pr"><tr id="3p5pr"><kbd id="3p5pr"></kbd></tr></em>
            <tbody id="3p5pr"><pre id="3p5pr"></pre></tbody>
            1. News & Events

              Updates from ET Healthcare

              China Association of Clinical Laboratory Practice Expo (CACLP)

              March 12–14, 2017
              Qingdao, China

              Allan S. Jaffe, MD, talks about the way forward for high sensitivity cardiac troponin.

              Alan H.B. Wu, PhD, reviews new developments in biomarkers and LC-MS applications in clinical practice.

              For more information on any of these activities, please contact us.


              Allan S. Jaffe, MD, chair of the Division of Clinical Core Laboratory Services in the Department of Laboratory Medicine and Pathology at Mayo Clinic, and a member of ET Healthcare’s Clinical Advisory Board, visited Tianjin, Qingdao, Beijing and Hangzhou recently to share his thoughts on the evolving role of high-sensitivity cardiac troponin in the diagnosis of acute myocardial infarction (AMI). He pointed out some key issues surrounding clinical application. See Figure 1. High on the agenda is consensus around the definition of a high-sensitivity cardiac troponin assay. He referred to the work of Fred S. Apple, PhD, DABCC, University of Minnesota, who proposed a framework (the Apple Score Card1) for classifying cardiac troponin assays based on analytical performance. See Figure 2. Dr. Jaffe reminded everyone that assay results are only a part of the picture about a given patient, and the clinician is the one who makes the diagnosis.

              1. Apple FS. A new season for cardiac troponin assays: it’s time to keep a score card. Clin Chem 2009;55(7):1303-1306.


              Alan H. B. Wu, PhD, Professor of Medicine, University of California San Francisco School of Medicine, Chief, Clinical Chemistry Laboratory at San Francisco General Hospital, and a member of ET Healthcare’s clinical advisory board, gave a series of lectures in Shanghai and Chongqing to bring clinicians and lab professionals up to date on developments in biomarkers of heart failure and clinical applications of LC-MS/MS.

              Dr. Wu highlighted the need to complement natriuretic peptides, key to diagnosis of acute dyspnea and short term risk stratification, with biomarkers for therapeutic monitoring—those focused on remodeling and fibrosis. He provided a framework for evaluating new biomarkers and suggested that galectin-3 and ST-2 appear most promising. (See Figures 1 and 2.) On clinical applications of LC-MS, he focused on four applications (vitamin D, hormones, immunosuppressants and toxicology) and explained where mass spectrometry can provide important information where existing technologies such as immunoassays cannot. For example, TOF-MS may enable presumptive detection of compounds without prior experience by the testing lab.

              韩国三级中文字幕hd 本道久久综合无码中文字幕| 精品国精品国产自在久国产| 毛片免费全部播放无码| 男女肉粗暴进来120秒动态图| 国产亚洲av片在线观看| 性饥渴的漂亮女邻居3| 农村老熟妇乱子伦视频| 香港三级经典全部| 欧洲熟妇色xxxx欧美老妇| 中文字幕精品一区二区| 欧美a级中文完在线看完整版|